Get started
Immunocore Holdings plc 2.5% 01-FEB-2030Immunocore Holdings plc 2.5% 01-FEB-2030Immunocore Holdings plc 2.5% 01-FEB-2030

Immunocore Holdings plc 2.5% 01-FEB-2030

No trades
See on Supercharts
Overview
Chart Analysis News

IMCR5997845 chart



Key terms


Outstanding amount
‪402.50 M‬ USD
Face value
1,000.00 USD
Minimum denomination
1,000.00 USD
Coupon
2.50% (Fixed)
Coupon frequency
Semi-annual
Yield to maturity
6.36%
Maturity date
Feb 1, 2030
Term to maturity
4 years

About Immunocore Holdings plc 2.5% 01-FEB-2030


Issuer
Immunocore Holdings Plc
Sector
Health Technology
Industry
Biotechnology
Home page
immunocore.com
Issue date
Feb 3, 2025
FIGI
BBG01L8DJZX1
Immunocore Holdings Plc operates as a commercial-stage biotechnology company pioneering the development of a novel class of TCR bispecific immunotherapies called ImmTAX – Immune mobilizing monoclonal TCRs Against X disease. Its lead product KIMMTRAK is a TCR therapeutic for the treatment of patients with unresectable or metastatic uveal melanoma, in the United States, European Union, Canada, Australia and the United Kingdom. Its pipeline products include IMC-F106C, IMC-F115C, IMC-F119C, IMC-F117C, IMC-F113V, IMC-I109V, IMC-SII8AI, among others. The company was founded on January 7, 2021 and is headquartered in Abingdon, the United Kingdom.

See how Immunocore Holdings Plc is moving with its highest-yielding bonds.

IMCR5997845 analysis


Advanced bond data for paid plans
Unlock important bond data including coupon rates, redemption details, risk assessments, and much more.

IMCR5997845 news